ARCHIVES

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Congress: Time Running out On Effort To Double Market Exclusivity Term

November 7, 1997

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

October 24, 1996

Overdiagnosis Can Result In Harm To Patients, Experts Say.

November 3, 2006

NCI Is Convinced It Has Isolated Human Cancer Virus

February 14, 1975

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005